Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

21.85
-1.2400-5.37%
Volume:104.46K
Turnover:2.23M
Market Cap:33.17M
PE:- -
High:22.85
Open:21.80
Low:20.67
Close:23.09
52wk High:152.22
52wk Low:11.52
Shares:1.52M
Float Shares:1.52M
Volume Ratio:2.03
T/O Rate:6.88%
Dividend:3.85
Dividend Rate:17.61%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI Shares Down 6.4%

THOMSON REUTERS
·
Jul 20

Tempus Publishes Investor Deck on Planned Personalis Acquisition to Expand MRD Testing Platform

Reuters
·
Jul 20

Sector Update: Healthcare

MT Newswires Live
·
Jul 20

Tempus AI Shares Fall 8.5% Premarket After Co to Acquire Personalis in $1.5 Bln Deal

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis for $1.5 Billion

Reuters
·
Jul 20

Tempus AI to acquire Personalis for $16.25 per share

TIPRANKS
·
Jul 20

Tempus AI Agrees to Buy Personalis for USD 16.25 Per Share in USD 1.5 Billion Deal

Reuters
·
Jul 20

Tempus AI Inc - Maximum Exchange Ratio Set at 0.3356 Tempus AI Shares Per Personalis Share

THOMSON REUTERS
·
Jul 20

Tempus - Consideration Structured as 100% Stock, Cash Option Capped at 50%

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (mrd) into Its Ai-enabled Precision Oncology Platform

THOMSON REUTERS
·
Jul 20

Tempus AI Inc - Cash Consideration Will be Financed with Cash on Hand and Borrowings Under Company's Then Existing Credit Facilities

THOMSON REUTERS
·
Jul 20

Dimon Warns AI Risks

AI Industry Frontlines
·
Jul 17

How Do Tempus AI’s (TEM) NHS Prostate Results Shape Its Clinical Credibility Narrative?

Simply Wall St.
·
Jul 17

AI Trading Has Become a 'Rubber Band,' Goldman Sachs Top Trader: The Question is 'When Will It Snap'

AI Industry Frontlines
·
Jul 17

AI Market Outlook; The Era Of Risk-Free Gains Has Come To An End

AI Industry Frontlines
·
Jul 17

Tempus Cites Real-world UK NHS Study Showing Prostate Pathology AI Changes Diagnosis in 5% of Cases

Reuters
·
Jul 16

Tempus AI is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 16

Tempus AI price target raised to $71 from $68 at TD Cowen

TIPRANKS
·
Jul 15

Anthropic Delays Claude Fable 5 Billing; OpenAI Removes GPT-5.6 Sol Usage Caps

AI Industry Frontlines
·
Jul 13

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of $1.91 Million in Common Shares

Reuters
·
Jul 11